Status:
COMPLETED
Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
Lead Sponsor:
University of California, Los Angeles
Conditions:
Progressive Supranuclear Palsy
Corticobasal Degeneration
Eligibility:
All Genders
35+ years
Brief Summary
Drug therapy of atypical parkinsonism is generally considered either ineffective or minimal 1. Therefore, there is an urgent need to find alternative therapies to treat atypical parkinsonian disorders...
Detailed Description
Background: Drug therapy of atypical parkinsonism is generally ineffective or minimal, and novel therapy approaches for atypical parkinsonian disorders are needed. Repetitive transcranial magnetic sti...
Eligibility Criteria
Inclusion
- If you are an adult with PSP or CBGD:
- 1\. Must be in good physical health.
- If you are neurologically healthy volunteers:
- 1\. Must be older than 35 years
Exclusion
- Must have no implanted metal. Dental fillings are acceptable.
- Must have no personal seizure or 1st degree relative with history of seizures
- Must not take any medication that lowers seizure threshold.
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01174771
Start Date
October 1 2008
End Date
February 1 2012
Last Update
May 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90095